H(2)Mab-19, an anti-human epidermal growth factor receptor 2 monoclonal antibody exerts antitumor activity in mouse oral cancer xenografts

Human epidermal growth factor receptor 2 (HER2) is reported to be overexpressed in breast cancers and is associated with poor clinical outcome. Trastuzumab is a humanized anti-HER2 antibody that offers significant survival benefits to patients with HER2-overexpressing breast cancer. In this study, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Takei, Junko, Kaneko, Mika Kato, Ohishi, Tomokazu, Kawada, Manabu, Harada, Hiroyuki, Kato, Yukinari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388441/
https://www.ncbi.nlm.nih.gov/pubmed/32765652
http://dx.doi.org/10.3892/etm.2020.8765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388441/
https://www.ncbi.nlm.nih.gov/pubmed/32765652
http://dx.doi.org/10.3892/etm.2020.8765

Ejemplares similares